Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 23.4 | uM | 5895.095 | 0.3210 | -0.0803 | 1.4629 | |
| 184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 4.68 | uM | 5896.095 | 0.2340 | -0.2149 | 1.5532 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 117 | uM | 5894.095 | 0.4918 | 0.3218 | 1.7133 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 4.68 | uM | 5895.095 | 0.3652 | 0.0046 | 1.4629 | |
| 184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.00749 | uM | 5896.095 | 0.9589 | 0.9467 | 1.5532 | |
| 184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.936 | uM | 5896.095 | 0.2987 | -0.0813 | 1.5532 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.187 | uM | 5894.095 | 1.0143 | 1.0167 | 1.7133 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 23.4 | uM | 5894.095 | 0.8199 | 0.7812 | 1.7133 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.00749 | uM | 5895.095 | 1.0112 | 1.0153 | 1.4629 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.936 | uM | 5895.095 | 0.4631 | 0.1817 | 1.4629 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 585 | uM | 5895.095 | 0.3541 | -0.0165 | 1.4629 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 2920 | uM | 5895.095 | 0.3946 | 0.0591 | 1.4629 | |
| 184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.0374 | uM | 5896.095 | 0.9593 | 0.9472 | 1.5532 | |
| 184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.187 | uM | 5896.095 | 0.7220 | 0.6217 | 1.5532 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.00749 | uM | 5894.095 | 0.9508 | 0.9420 | 1.7133 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.0374 | uM | 5894.095 | 0.9978 | 0.9974 | 1.7133 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.936 | uM | 5894.095 | 1.0198 | 1.0230 | 1.7133 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 4.68 | uM | 5894.095 | 0.7840 | 0.7352 | 1.7133 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 585 | uM | 5894.095 | 0.2174 | -0.1792 | 1.7133 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 2920 | uM | 5894.095 | 0.3330 | 0.0526 | 1.7133 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.0374 | uM | 5895.095 | 0.9618 | 0.9475 | 1.4629 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.187 | uM | 5895.095 | 0.8564 | 0.7989 | 1.4629 | |
| 184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 117 | uM | 5895.095 | 0.3334 | -0.0561 | 1.4629 | |
| 184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 117 | uM | 5896.095 | 0.1824 | -0.3313 | 1.5532 | |
| 184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 23.4 | uM | 5896.095 | 0.1870 | -0.3204 | 1.5532 |